Reformation Inc. (REF) News
Follow Reformation Inc. (REF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Reformation Inc. 2026: Revenue $155.23M, EPS $0.23— 10-Q Summary
Reformation Inc. reported results for the 2026 quarter with revenue of $155.23M and diluted EPS of $0.23, driven by continued direct-to-consumer and wholesale growth that supported a rise in net income to $12.41M versus
EARNINGS | Sep 11, 2026, 09:22 PM UTC
M
Reformation reports 24% Q2 net revenue growth
Reformation said second-quarter net revenue rose 24% year over year and gave full-year 2026 guidance for net revenue and adjusted EBITDA margin. The company also said it used IPO proceeds to repay debt and reduce net lev
EQUITY | Sep 11, 2026, 05:44 AM UTC
M
Reformation reports Q2 revenue up 24% and higher gross margin
Q2 2026 revenue grew 24%, gross margin was 66.7%, and active customers rose 23% year-over-year. The company guided FY 2026 revenue growth of 18.6%–19.5% and adjusted EBITDA margin of 14.0%–14.2%.
EQUITY | Sep 10, 2026, 10:51 PM UTC
M
Reformation Q2 revenue rises 24%, EBITDA up 54%
Reformation said second-quarter revenue grew 24% and adjusted EBITDA rose 54%. It also cited strong international and omni-channel expansion and said IPO proceeds reduced leverage.
EQUITY | Sep 10, 2026, 10:26 PM UTC
M
Reformation posts $12.4m net income in first quarter since IPO
Reformation reported net income of $12.4 million for the three months ended June 27, up from $6.92 million last year, in its first quarterly earnings as a publicly traded company. The company also reported higher revenue
EARNINGS | Sep 10, 2026, 08:57 PM UTC
M
REF net income surges 79.4% as revenue grows 24.1%
Net revenue rose 24.1% year over year, while adjusted EBITDA margin expanded to 16.4%. The update says growth was broad-based across DTC, wholesale and international channels, with strong guidance for fiscal 2026.
EARNINGS | Sep 10, 2026, 08:16 PM UTC
L
Reformation to announce Q2 FY2026 results Sept. 10, 2026
Reformation said it will announce second quarter fiscal 2026 results on September 10, 2026.
EARNINGS | Aug 27, 2026, 01:01 PM UTC
L
Reformation to announce Q2 fiscal 2026 results Sept. 10, 2026
Reformation said it will announce second-quarter fiscal 2026 results on September 10, 2026.
EARNINGS | Aug 27, 2026, 01:00 PM UTC
H
Reformation Rises in NYSE Debut
Reformation scores winning session
EQUITY | Jul 31, 2026, 12:55 PM UTC
L
REF - IPO opens at $15.00, was priced there.
REF - IPO opens at $15.00, was priced there.
EQUITY | Jul 30, 2026, 04:08 PM UTC
H
Jersey Mike's Raises $1 Billion
Jersey Mike's raises $1 billion ahead of NYSE debut
EQUITY | Jul 30, 2026, 01:12 PM UTC
L
REF - Reformation 14.06M share IPO priced at $15.00, range was $15 - $17
REF - Reformation 14.06M share IPO priced at $15.00, range was $15 - $17
EQUITY | Jul 30, 2026, 12:52 AM UTC
H
Reformation Prices Initial Public Offering
Reformation announces IPO pricing
EQUITY | Jul 29, 2026, 11:01 PM UTC
H
Opening Day: Scribe Therapeutics makes strong trading debut
Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the market with cardiometabolic programs at the forefront and early momentum beh
MNA | Jul 27, 2026, 03:21 PM UTC
L
Opening Day: IPO momentum continues with Standard Nuclear, Csquare
Standard Nuclear, QumulusAI and Csquare stepped onto the public stage last week, kicking off a diverse slate of debuts spanning next generation nuclear fuel, distributed AI compute and large scale data centers. LATEST IP
EARNINGS | Jul 20, 2026, 03:00 PM UTC